These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 938576)

  • 41. Occurrence and some properties of a protein-like inhibitor of dopamine beta-hydroxylase in rat liver.
    Oyama H; Izumi H; Ozawa H; Tuboi S
    Biochem Pharmacol; 1977 Nov; 26(21):1985-90. PubMed ID: 336050
    [No Abstract]   [Full Text] [Related]  

  • 42. A time-resolved assay of dopamine beta-hydroxylase activity utilizing high-pressure liquid chromatography.
    Feilchenfeld NB; Richter HW; Waddell WH
    Anal Biochem; 1982 May; 122(1):124-8. PubMed ID: 7103078
    [No Abstract]   [Full Text] [Related]  

  • 43. A radioimmunoassay for dopamine-beta-hydroxylase using a glass-bound antibody.
    Kashimoto T; Park D; Ebstein RP; Goldstein M; Levitz M; Yaverbaum S
    Experientia; 1974 Nov; 30(11):1363-4. PubMed ID: 4435194
    [No Abstract]   [Full Text] [Related]  

  • 44. Indirect and direct inhibition of dopamine beta-hydroxylase by amphetamine in storage vesicles and synaptosomes.
    Lau C; Slotkin TA
    Br J Pharmacol; 1976 Jun; 57(2):223-8. PubMed ID: 779909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine-beta-hydroxylase: a tetrameric glycoprotein.
    Wallace EF; Krantz MJ; Lovenberg W
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2253-5. PubMed ID: 4525162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unsaturated heterocyclic amines as potent time-dependent inhibitors of dopamine beta-hydroxylase.
    Bargar TM; Broersma RJ; Creemer LC; McCarthy JR; Hornsperger JM; Palfreyman MG; Wagner J; Jung MJ
    J Med Chem; 1986 Mar; 29(3):315-7. PubMed ID: 3950911
    [No Abstract]   [Full Text] [Related]  

  • 47. Prenatal reserpine administration: permanent changes in adrenal tyrosine hydroxylase and dopamine beta-hydroxylase.
    Bartolomé J; Slotkin TA
    Psychopharmacol Commun; 1975; 1(5):465-72. PubMed ID: 7001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of unithiol (2-mercapto-propane-sulfonate sodium) on amphetamine stimulated motor activity, evipan anesthesia and dopamine beta hydroxylase activity].
    Stoĭchev T; Koleva M; Kirova A
    Eksp Med Morfol; 1974; 13(2):118-23. PubMed ID: 4465084
    [No Abstract]   [Full Text] [Related]  

  • 49. Purification and immunochemical characterization of dopamine beta-hydroxylase from human pheochromocytoma.
    Park DH; Kashimoto T; Ebstein RP; Goldstein M
    Mol Pharmacol; 1976 Jan; 12(1):73-81. PubMed ID: 943692
    [No Abstract]   [Full Text] [Related]  

  • 50. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D; Da Prada M; Pletscher A
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cysteamine effects on monoamines, dopamine-beta-hydroxylase and the hypothalamic-pituitary axis.
    Terry LC; Craig R
    Neuroendocrinology; 1985 Dec; 41(6):467-75. PubMed ID: 4080089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of dopamine-beta-hydroxylase in vitro in rat heart & adrenal tissue.
    Srivastava M; Kapoor NK
    Indian J Exp Biol; 1980 Jun; 18(6):647-9. PubMed ID: 6254872
    [No Abstract]   [Full Text] [Related]  

  • 53. Evidence for a localization of dopamine-beta-hydroxylase within the chromaffin granules.
    Laduron PM
    FEBS Lett; 1975 Mar; 52(1):132-4. PubMed ID: 1123076
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma dopamine beta-hydroxylase species dependence and in the vitro influence of NEM, coppor, and PH.
    Frigon RP; Converse JL; Stone RA
    Biochem Med; 1978 Feb; 19(1):1-15. PubMed ID: 23770
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine beta-hydroxylase. Demonstration of enzymatic ketonization of the product enantiomer S-octopamine.
    May SW; Phillips RS; Mueller PW; Herman HH
    J Biol Chem; 1981 Mar; 256(5):2258-61. PubMed ID: 6780561
    [No Abstract]   [Full Text] [Related]  

  • 57. Trans-synaptic induction of dopamine (3,4-dihydroxyphenethylamine) -hydroxylase in adrenergic tissues of the rat.
    Molinoff PB; Brimijoin S; Axelrod J
    Biochem J; 1971 Jul; 123(4):32P-33P. PubMed ID: 4399553
    [No Abstract]   [Full Text] [Related]  

  • 58. BRL 8242 (2-[2-benzimidazolyl]-amino-2-imidazoline dihydrochloride), a new inhibitor of dopamine-beta-hydroxylase with antihypertensive activity.
    Claxton IM; Palfreyman MG; Poyser RH; Whiting RL
    Eur J Pharmacol; 1976 May; 37(1):179-88. PubMed ID: 1278239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Developmental pattern of dopamine beta-hydroxylase induction in the adrenals of the rat. Influence of neonatal hypothyroidism.
    Chami N; Gripois D
    J Dev Physiol; 1988 Oct; 10(5):445-9. PubMed ID: 3221059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced plasma dopamine-beta-hydroxylase activity in familial dysautonomia.
    Weinshilboum RM; Axelrod J
    N Engl J Med; 1971 Oct; 285(17):938-42. PubMed ID: 5096225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.